ResMed Acquires Sleep Apnea Firm

(San Diego, CA, USA) has acquired Map Medizin-Technologie GmbH (Munich, Germany) for US$69 million in cash. ResMed develops and markets medical equipment for treating sleep-disordered breathing. Map also develops and markets medical devices for sleep-disordered breathing, with a focus on obstructive sleep apnea.

"Map's strengths in R&D, sales, and marketing complement those of ResMed and will strengthen ResMed's market leadership position in Europe,” said Christopher Roberts, executive vice president of ResMed.

"…We believe that we will now have the resources to make an even stronger contribution with innovative devices for the diagnosis and treatment of sleep-disordered breathing,” said Dr. Stefan Madaus, CEO of Map.



Related Links:
Resmed Inc.